Comparative effectiveness of natalizumab and fingolimod over a follow-up longer than 2 years has been not addressed yet.
Long-term comparative analysis of no evidence of disease activity (NEDA-3) status between multiple sclerosis patients treated with natalizumab and fingolimod for up to 4 years
Guerra, Tommaso;Caputo, Francesca;Orlando, Bianca;Paolicelli, Damiano;Trojano, Maria;Iaffaldano, Pietro
2021-01-01
Abstract
Comparative effectiveness of natalizumab and fingolimod over a follow-up longer than 2 years has been not addressed yet.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Guerra2021_Article_Long-termComparativeAnalysisOf.pdf
accesso aperto
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
854.06 kB
Formato
Adobe PDF
|
854.06 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
